Evaluation of anti-atherosclerotic and vasculoprotective effect of long acting nifedipine in patients after PTCA.
J Indian Med Assoc
;
2001 Sep; 99(9): 519-20, 522
Artículo
en Inglés
| IMSEAR
| ID: sea-100293
ABSTRACT
The anti-atherosclerotic and vasculoprotective effect of long acting nifedipine (nicardia retard 20) was evaluated on patients undergoing percutaneous transluminal coronary angioplasty (PTCA). This was a randomised, controlled, prospective clinical trial. A total of 30 patients fulfilling inclusion criteria were divided randomly in 2 groups of 15 each. One group was given long acting nifedipine while other group did not receive long acting nifedipine. The rest of the treatment was similar for both the groups. Clinical and angiographic parameters were evaluated regularly for a period of one year. The group receiving long acting nifedipine showed 20% restenosis as against 33% in group not receiving long acting nifedipine. Thus, from this trial, it can be concluded that long acting nifedipine can reduce the progress of reocclusion and thus demonstrates the anti-atherosclerotic and vasculoprotective action.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Vasodilatadores
/
Enfermedad de la Arteria Coronaria
/
Femenino
/
Humanos
/
Masculino
/
Bloqueadores de los Canales de Calcio
/
Nifedipino
/
Angioplastia Coronaria con Balón
/
Análisis de Supervivencia
/
Preparaciones de Acción Retardada
Tipo de estudio:
Ensayo Clínico Controlado
Idioma:
Inglés
Revista:
J Indian Med Assoc
Año:
2001
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS